| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| YA Yinka Akinsola Blue Trust Inc. | 1,122 | $4,420.68 | $6,574.92 | $2,154.24 | 48.73% |
| Biotechnology Industry | Healthcare Sector | Bradley E. Burnam CEO | NASDAQ (NMS) Exchange | 90021W105 CUSIP |
| US Country | 2 Employees | - Last Dividend | - Last Split | - IPO Date |
Global Health Solutions, Inc., operating under the name Turn Therapeutics, is a dynamic pharmaceuticals company dedicated to developing innovative treatments for various diseases affecting the skin, nails, and eyes. Incorporated in 2015 and headquartered in Westlake Village, California, the company specializes in leveraging advanced delivery technologies that allow for deeper penetration into the skin and nails. This approach not only enhances the efficacy of their products but also plays a crucial role in reducing antibiotic resistance, an increasingly prevalent issue in acute and chronic wound care environments. Turn Therapeutics aims to equip healthcare institutions with effective solutions that address a wide spectrum of skin conditions, from urgent acute wounds to longer-term chronic dermatoses.
These products are specifically designed to address urgent skin injuries, promoting faster healing and reducing the risk of infection through advanced formulations that penetrate deeply to deliver active ingredients effectively.
Tailored for patients dealing with long-lasting and complex wounds, these solutions focus on providing sustained relief and support, integrating technology that mitigates antibiotic resistance while promoting natural healing processes.
This range of products targets various skin conditions and dermatoses, utilizing innovative delivery mechanisms to ensure effective treatment of issues such as eczema, psoriasis, and other inflammatory skin disorders.
Addressing problems specifically related to the nails, these products are formulated to treat fungal infections and other nail disorders, ensuring both health and aesthetic appeal by promoting robust nail growth and recovery.
Focused on ocular health, these therapeutics aim to provide relief from eye-related conditions through advanced drug formulations that effectively target inflammation and infection while ensuring minimal side effects.